Abstract
Background
Gastric restrictive procedures are considered effective weight loss treatment for severe obesity. The aim of the study was to evaluate the efficacy and safety of a reversible implant that renders a partial restriction of stomach in a canine model.
Methods
The device was comprised of two longitudinal parallel non-compressive plates with two C-rings to create a small gastric pouch that opposed gastric distension. Three groups of non-obese mongrel dogs were included: group I (n = 6) underwent surgical implant for 6 weeks, group II (n = 6) underwent surgical implant for 6 weeks, followed by surgical removal of the implant and additional monitoring for 5 weeks, and group III (n = 5) served as sham-operated controls for groups I and II. Food intake and body weight were monitored, and the stomachs were examined histologically postmortem.
Results
The average food intake was significantly decreased by 38.2% in group I as compared to group III throughout the 6 weeks of surgical implant (P < 0.05). The implanted dogs showed a progressive weight loss as compared to sham, which reached 21% by the end of 6 weeks. In group II, after 5 weeks of implant removal, the body weights recovered to approximately 96% of baseline. Histological evidence of the implant site at the gastric walls revealed no significant structural changes, tissue ischemia, hemorrhage, or necrosis.
Conclusion
Our results validate the feasibility of a reversible gastric restriction implant in a non-obese canine model, with the potential for achieving significant weight loss within 6 weeks and with no injury to the gastric wall.
Similar content being viewed by others
References
Silventoinen K, Sans S, Tolonen H, et al. Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord. 2004;28:710–8.
do Carmo I, dos Santos O, Camolas J, et al. Prevalence of obesity in Portugal. Obes Rev. 2006;7:233–7.
Iannelli A, Dainese R, Piche T, et al. Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol. 2008;14:821–7.
Suzuki S, Ramos EJ, Goncalves CG, et al. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery. 2005;138:283–90.
Schneider BE, Mun EC. Surgical management of morbid obesity. Diab Care. 2005;28:475–80.
Kushner R. Diets, drugs, exercise, and behavioral modification: where these work and where they do not. Surg Obes Relat Dis. 2005;1:120–2.
Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995;118:599–606.
Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114:217–23.
Buchwald H, Cowan GSM, Pories WJ, editors. Surgical management of obesity. Pennsylvania: Saunders; 2007. p. 102–7.
Martin L, Tan T, Holmes P, et al. Can morbidly obese patients lose weight preoperatively? Am J Surg. 1995;169:245–53.
Maclean LD, Rhode BM, Sampalis J. Results of the surgical treatment of obesity. Am J Surg. 1993;165:155–9.
Mason EE. Morbid obesity: use of vertical banded gastroplasty. Surg Clin North Am. 1987;67:521–53.
Rubin M, Yehoshua RT, Stein M, et al. Laparoscopic sleeve gastrectomy with minimal morbidity. Early results in 120 morbidly obese patients. Obes Surg. 2008;18:1567–70.
Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.
Buchwald H, Cowan GSM, Pories WJ, editors. Surgical management of obesity. Pennsylvania: Saunders; 2007. p. 267–77.
Naslund E, Backman L, Granstrom L, et al. Seven year results of vertical banded gastroplasty for morbid obesity. Eur J Surg. 1997;163:281–6.
MacLean JD, Rhode BM, Forse RA. Late results of vertical banded gastroplasty for morbid and super obesity. Surgery. 1990;107:20–7.
Gorecki P, Wise L, Brolin RE, et al. Complications of combined gastric restrictive and malabsorptive procedures: part 1. Curr Surg. 2003;60:138–44.
Morino F, Toppino M, Fronda G, et al. Weight loss and complications after vertical banded gastroplasty. Obes Surg. 1992;2:69–73.
Frezza EE, Reddy S, Gee LL, et al. Complications after sleeve gastrectomy for morbid obesity. Obes Surg. 2009;19:684–7.
Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.
Guo X, Mattar S, Morales C, et al. Novel gastric sleeve magnetic implant: safety and efficacy in rats. Surg Obes Relat Dis. 2009;5:684–91.
Woodward B. Bariatric surgery options. Crit Care Nurs Q. 2003;26:89–100.
Fisher BL, Little AG. Vertical silastic ring gastroplasty with Nissen fundoplication prevents reflux. Obes Surg. 1996;6:233–6.
Goergen M, Arapis K, Limgba A, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty: results of a 2-year follow-up study. Surg Endosc. 2007;21:659–64.
Brolin EB, Robertson LB, Kenler HA. Weight loss and dietary intake after vertical banded gastroplasty and Roux-en-Y gastric bypass. Ann Surg. 1994;220:782–90.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–30.
Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.
Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–61.
Cohen R, Uzzan B, Bihan H, et al. Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes Surg. 2005;15:1501–2.
Foschi D, Corsi F, Rizzi A, et al. Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. Obes Surg. 2005;15:1129–32.
Hanusch-Enserer U, Brabant G, Roden M. Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. N Engl J Med. 2003;348:2159–60.
Acknowledgment
This research was funded by GRest, Inc. and NIH SBIR Phase I grant R43DK083889. We wish to thank Mr. Mitchell L Keel and Mark Svendsen for excellent technical assistance.
Disclosures
GSK is founder of GRest, Inc. There are no other conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guo, X., Zheng, H., Mattar, S.G. et al. Reversible Gastric Restriction Implant: Safety and Efficacy in a Canine Model. OBES SURG 21, 1444–1450 (2011). https://doi.org/10.1007/s11695-010-0299-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-010-0299-4